Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ping An Biomedical ( (PASW) ) has shared an announcement.
In October 2025, Ping An Biomedical Co., Ltd. announced significant changes in its leadership team. The company accepted the resignations of several key executives, including the Chairman, CEO, CFO, and an independent director, all citing personal reasons for their departure. Subsequently, the company appointed Mr. Pijun Liu as the new Chairman, CEO, and Executive Director, Ms. Hongli Yang as the new CFO, and Mr. Xianzhi Liu as an independent director, effective October 14, 2025. These leadership changes are expected to influence the company’s strategic direction and operational focus.
More about Ping An Biomedical
Average Trading Volume: 1,615,983
Find detailed analytics on PASW stock on TipRanks’ Stock Analysis page.